Updated Guidelines Issued by American College of Radiology
Updated guidelines help radiologists choose appropriate medical imaging exam for a patient's clinical condition.
The American College of Radiology has issued new and updated evidence-based guidelines to help radiologists choose the most appropriate medical imaging exam for a patient’s clinical condition.
The latest version of the American College of Radiology (ACR) Appropriateness Criteria® updates 39 appropriateness criteria topics and adds five new criteria. The new screening criteria include breast cancer screening and imaging of mesenteric ischemia.
“ACR Appropriateness Criteria can help providers identify when they can replace an exam that uses ionizing radiation with one that does not, or even when no imaging exam may be needed at all,” said E. Kent Yucel, MD, FACR, chair of the ACT Committee on Diagnostic Imaging and Interventional Radiology Appropriateness Criteria. “This can reduce patient and population exposure to radiation, and ensure appropriate imaging, without disrupting the doctor-patient relationship or delaying needed care.”
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
